319 related articles for article (PubMed ID: 29528966)
1. In Case you Missed It-Basic Science Advances in Transplantation 2017.
Baan CC
Transplantation; 2018 Jun; 102(6):932-934. PubMed ID: 29528966
[TBL] [Abstract][Full Text] [Related]
2. Current concepts and perspectives of immunosuppression in organ transplantation.
Scherer MN; Banas B; Mantouvalou K; Schnitzbauer A; Obed A; Krämer BK; Schlitt HJ
Langenbecks Arch Surg; 2007 Sep; 392(5):511-23. PubMed ID: 17450373
[TBL] [Abstract][Full Text] [Related]
3. Randall E. Morris, MD, FRCP: Stanford University School of Medicine and former Global Head of Transplantation Therapeutic Area (Discovery Research) and Global Head of Transplantation Translational Medicine, Novartis, AG, Basel, Switzerland.
Morris RE
Transplantation; 2015 Aug; 99(8):1544-6. PubMed ID: 26308300
[No Abstract] [Full Text] [Related]
4. Organ Procurement and Transplantation Network/Scientific Registry of Transplant Recipients 2014 Data Report: Intestine.
Cai J; Wu G; Qing A; Everly M; Cheng E; Terasaki P
Clin Transpl; 2014; ():33-47. PubMed ID: 26281125
[TBL] [Abstract][Full Text] [Related]
5. Transplant immunopharmacology: you can fool with mother nature!
Vasquez EM; Westin ED
Nurs Case Manag; 1999; 4(1):37-48. PubMed ID: 10232222
[TBL] [Abstract][Full Text] [Related]
6. Immunologic aspects and rejection in solid organ versus reconstructive transplantation.
Hautz T; Brandacher G; Zelger B; Gorantla VS; Lee AW; Pratschke J; Schneeberger S
Transplant Proc; 2010 Nov; 42(9):3347-53. PubMed ID: 21094778
[TBL] [Abstract][Full Text] [Related]
7. International Organ Protection Symposium: The fusion of engineering and medicine.
Jia JJ; Li JH; Xin L; Li HY; Badiwala M; Sun Y; Xu X; Zheng SS
Hepatobiliary Pancreat Dis Int; 2019 Dec; 18(6):601-602. PubMed ID: 31378474
[No Abstract] [Full Text] [Related]
8. What's hot, what's new at WTC--clinical science.
Mueller TF; Oberkofler CE; Clavien PA
Am J Transplant; 2015 Feb; 15(2):327-32. PubMed ID: 25612489
[TBL] [Abstract][Full Text] [Related]
9. Maintenance immunosuppressants in the management of antibody-mediated renal allograft rejection: which regimen is best?
Zhou Y; Li X; Liu Y; Sun Q
Immunotherapy; 2017 Jan; 9(1):47-55. PubMed ID: 28000532
[TBL] [Abstract][Full Text] [Related]
10. New directions for induction immunosuppression strategy in solid organ transplantation.
Hawksworth JS; Leeser D; Jindal RM; Falta E; Tadaki D; Elster EA
Am J Surg; 2009 Apr; 197(4):515-24. PubMed ID: 19249743
[TBL] [Abstract][Full Text] [Related]
11. An update on chemical pharmacotherapy options for the prevention of kidney transplant rejection with a focus on costimulation blockade.
Kälble F; Schaier M; Schäfer S; Süsal C; Zeier M; Sommerer C; Morath C
Expert Opin Pharmacother; 2017 Jun; 18(8):799-807. PubMed ID: 28460546
[TBL] [Abstract][Full Text] [Related]
12. Tolerance induction.
Kupiec-Weglinski JW
Curr Opin Organ Transplant; 2008 Aug; 13(4):331-2. PubMed ID: 18685325
[No Abstract] [Full Text] [Related]
13. Humanized Monoclonal Antibody Alemtuzumab Treatment in Transplant.
Bhowmick M; Auckbarallee F; Edgar P; Ray A; Dasgupta S
Exp Clin Transplant; 2016 Feb; 14(1):17-21. PubMed ID: 26862819
[TBL] [Abstract][Full Text] [Related]
14. Generic immunosuppression in solid organ transplantation: a Canadian perspective.
Harrison JJ; Schiff JR; Coursol CJ; Daley CJ; Dipchand AI; Heywood NM; Keough-Ryan TM; Keown PA; Levy GA; Lien DC; Wichart JR; Cantarovich M
Transplantation; 2012 Apr; 93(7):657-65. PubMed ID: 22267158
[TBL] [Abstract][Full Text] [Related]
15. Roles of toll-like receptors signaling in organ transplantation.
Li T; Chen G; Zhang Z
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2011 Dec; 36(12):1125-33. PubMed ID: 22246357
[TBL] [Abstract][Full Text] [Related]
16. Recent advances in immunosuppressive therapy for prevention of renal allograft rejection.
Lunsford KE; Barbas AS; Brennan TV
Curr Opin Organ Transplant; 2011 Aug; 16(4):390-7. PubMed ID: 21666473
[TBL] [Abstract][Full Text] [Related]
17. The Role of Patient-reported Outcomes and Medication Adherence Assessment in Patient-focused Drug Development for Solid Organ Transplantation.
Karpen SR; Klein A; Alloway RR; Albrecht R; Belen O; Campbell M; Kluetz P; Minasian LM; Mitchell SA; O'Doherty I; Papadopoulos E; Sapir-Pichhadze R; Spear N; van Gelder T; Velidedeoglu E; Page CA; Everly MJ
Transplantation; 2021 May; 105(5):941-944. PubMed ID: 33901129
[No Abstract] [Full Text] [Related]
18. Nonadherence to therapy after adult solid organ transplantation: A focus on risks and mitigation strategies.
Doyle IC; Maldonado AQ; Heldenbrand S; Tichy EM; Trofe-Clark J
Am J Health Syst Pharm; 2016 Jun; 73(12):909-20. PubMed ID: 27189855
[No Abstract] [Full Text] [Related]
19. The Influence of Immunosuppressive Agents on the Risk of De Novo Donor-Specific HLA Antibody Production in Solid Organ Transplant Recipients.
OʼLeary JG; Samaniego M; Barrio MC; Potena L; Zeevi A; Djamali A; Cozzi E
Transplantation; 2016 Jan; 100(1):39-53. PubMed ID: 26680372
[TBL] [Abstract][Full Text] [Related]
20. Transplantation. Save our bacon!
Henry ML
Lancet; 1997 Dec 20-27; 350 Suppl 3():SIII28. PubMed ID: 9465203
[No Abstract] [Full Text] [Related]
[Next] [New Search]
